Friday, March 29, 2019
The purpose of this transmittal is to introduce Policy Number: HCDMA-19-001 which removes the Prior Authorization requirements for Buprenorphine containing drug products and Vivitrol.
To find support and resources for federal workers, visit fedsupport.dc.gov.
The purpose of this transmittal is to introduce Policy Number: HCDMA-19-001 which removes the Prior Authorization requirements for Buprenorphine containing drug products and Vivitrol.